New report demonstrates the growing importance of partnerships in advancing biomedical innovation

As we mark a full year since COVID-19 was declared a global pandemic, it ’s impossible to overstate the significance of collaborations. The unprecedented level of strategic collaborative efforts that have taken place across the biopharmaceutical ecosystem have been central to efforts to ensure efficient development, manufacture and distribution of critical COVID-19 vac cines and treatments. The coronavirus outbreak has brought new attention to the importance of these innovative cross-stakeholder partnerships. Anew report from PhRMA looks broadly at the collaborative ecosystem and illustrates biopharmaceutical industry ’s long history and vast experience with a diverse breadth of collaborative efforts. 
Source: The Catalyst - Category: Pharmaceuticals Authors: Source Type: news